Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @DrRajivsankar
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DrRajivsankar
-
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction
Rationale and Design of GALACTIC-HF
http://heartfailure.onlinejacc.org/content/early/2020/01/08/j.jchf.2019.12.001?utm_medium=email_newsletter&utm_source=jchf&utm_campaign=AIP&utm_content=20200205 …
@JACCJournals@secardiologia@SACardiologia@escardiopic.twitter.com/sDtx5nYAzt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
#Ep12 Sudden Cardiac Death in Heart Failure with Nasrien Ibrahim, MD@IAmDrIbrahim http://heartsuccess.info iTUnes https://podcasts.apple.com/us/podcast/heartsuccess-a-heart-failure-podcast/id1473364784?fbclid=IwAR18CAjefIlI0eFz3lVXP40rLlhQ8V-ltq-qILVOIKhy1Doi4m_r306g0ug … Google https://podcasts.google.com/?feed=aHR0cDovL2hlYXJ0c3VjY2Vzc3RlYW0ubGlic3luLmNvbS9yc3M%3D&fbclid=IwAR2o1lrqNtmAqgOZsNOIfKjgco5yAsPnOh5KTEhJznEixf4GQ1Mtwn_3rZQ … YouTube https://www.youtube.com/watch?v=TDyYlR9GrYM&list=PLsDc6PBnleQC3KF-8jxSz-eYzd_-lxSWb&index=13 … CastBox https://castbox.fm/channel/HeartSuccess-A-Heart-Failure-Podcast-id2206974?country=us …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
SGLT2i for patients with T2DM and CKD
trials supports the role of SGLT2i to prevent kidney and CV events in
with T2DM
lower levels of eGFR and higher levels of albuminuria are among those who stand to gain the greatest absolute benefits @VladoPerkovic@secardiologiapic.twitter.com/zZV2pJkLb3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Diabetes in patients with HFrEF is associated with distinct pathophysiological pathways related to inflammation.
These data support the evaluation of anti-inflammatory therapeutic approaches
http://heartfailure.onlinejacc.org/content/early/2020/01/08/j.jchf.2019.11.005?utm_medium=email_newsletter&utm_source=jchf&utm_campaign=AIP&utm_content=20200205 …
@JACCJournals@almucastro01@MAROSFO@R_Campuzano_Rpic.twitter.com/jvMlBz4dtB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
New
#JACCHF State-of-the-Art Review: Could this be a game changer in#heartfailure treatment? Check out the methods paper for the#GALACTICHF trial, which explores the effect of omecamtiv mecarbil, a novel cardiac myosin activator, in chronic#HFrEF. https://bit.ly/2GYhU21 pic.twitter.com/ySzRiSmhjV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Max fixed energy shocks vs escalated shocks in DCCV for AF - First presented at ESC Congress 2019. Now in this weeks EHJ edition. That's a reminder that ESC Congress 2020 abstract deadline is fast approaching!!! https://www.escardio.org/Congresses-&-Events/ESC-Congress …
@escardioHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
HF awareness week--critical to raise awareness of this disease thats common, highly morbid, and on the rise--exciting new treatments available but have to raise awareness to impact public health
#HFWeek2020#HFSAhttps://twitter.com/HFSA/status/1224395141944877058 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Macrovascular Endothelial Dysfunction beyond effect of
#OSA & T2#Diabetes alone: https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/obstructive-sleep-apnea-with-type-2-diabetes-and-macrovascular-endothelial-dysfunction/ … Investigators recommend including assessment of#OSA in future T2D trials You would agree@Dominik_LinzPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Heart Failure Awareness Week kicks off THIS WEEKEND! We'll be tweeting all this week, sharing ways you can participate.

Make sure you're signed up to be a promoter on social media via our PostSpeaker campaign. #HFWeek2020 http://www.hfsa.org/hfweek2020 pic.twitter.com/VH0iYxXnln
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
REDUCE-IT USA now published in print in Circulation! Mortality reduction seen in this cohort with multiple cardiovascular risk factors. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.044440#.Xjn0Sd6Hvc8.twitter …
@DLBhattMD@mmillermd1@CBallantyneMD@gabrielstegHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
#CVD is the major cause of mortality in elderly women diagnosed with#breast cancer with a 30% increased risk of cardiovascular events particularly#heartfailure https://bit.ly/2RWNm7m#WorldCancerDay
@MAC_MEPs#cardiotoxicity#ESCardioOnco#cardiotwitterpic.twitter.com/JbFfQB8ifI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysishttps://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002983 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Dr. Sana Al-Khatib: do you know and EP who is a Preventive Cardiologist? She is one!
@ASPCardio#HeartintheDesert
lower rates of SCD in
: autopsy data 21%
vs 79%
ICDs save lives but used less in
her work supports lower mortality in
with ICDpic.twitter.com/AsmAyDnUiF
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Empagliflozin in ADHF: no effect on change in VAS dyspnoea, diuretic response, NT‐proBNP, and length of hospital stay, but
urinary output and
combined endpoint of worsening HF, rehospitalization for HF or death at 60d @hvanspall@gcfmd@JJheart_dochttps://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1713#.XjhTrI-ucnA.twitter …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
We are delighted to announce details for our Heart Failure: Don’t Fail to Function Masterclass, 12 Jun 2020, London have been published and registration is now open. To register or find out more details about this event, please see our website https://buff.ly/2GCGuVX
@ukcpahfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Great choice by
@ehj_ed@TomLuscher In this article effect magnitude of Dapaglifozin is compared with recent#HFrEF therapies in RCTs such as PARADIGM-HF, SHIFT & EMPHASIS-HF@ShelleyZieroth@hvanspall@SABOURETCardio@GordFogg@rahatheart1@IAmDrIbrahim@MarcoMetra@escardiohttps://twitter.com/ehj_ed/status/1223279044097118212 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
#CardioTwitter is buzzing with discussion on coronary microvascular dysfunction! Timely for#CircIntvJC#TwitterChat today 02-02-2020
with @CircIntv#SoMe Editor@fischman_david @CircOutcome@CircAHA@JAHA_AHA@DocSavageTJU#AHAJournals#ACCFIT#AHAFITpic.twitter.com/768QMhAtXc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Sex & gender in cardiovascular medicine: presentation & outcomes of
#AcuteCoronarySyndrome https://bit.ly/2urk7jm@escardio@ehj_ed#EHJ#ESCYoung#cardiotwitter#freeaccesspic.twitter.com/t6YXmoASM5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
Ongoing trials are addressing the role of SGLT2i in patient with HF and preserved ejection fraction and chronic kidney disease,with and without T2DM https://doi.org/10.1016/j.jacc.2019.11.036 …
@ACCinTouch@ACCMass@escardio@lamcardio@ErinMichos@DLBHATTMD@AnastasiaSMihai@ALEX_MISCHIE@nossikoffpic.twitter.com/Bfmjy5GfHm
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP proslijedio/la je Tweet
@hvanspall can break down a complicated issue so wonderfully. She came so far for us today &. I am so proud to know her. Thank you for your efforts dear Harriette! You made my CME amazing!@loriannpeterso1@uazmedphx@rajdoc2005@JJheart_doc@IAmDrIbrahim@iamritu@mmamas1973https://twitter.com/drmarthagulati/status/1223744981908635650 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
